Benjamin Chi Yin Wai

Title: Innovations of Benjamin Chi Yin Wai in Liver Cancer Diagnosis

Introduction

Benjamin Chi Yin Wai is an accomplished inventor based in Burnaby, Canada. He has made significant contributions to the field of medical diagnostics, particularly in the area of liver cancer. With a total of 3 patents to his name, his work focuses on developing non-invasive methods for diagnosing and monitoring liver cancer.

Latest Patents

One of his latest patents involves a specific biomarker set for the non-invasive diagnosis of liver cancer. This invention identifies a unique set of proteins and tumor antigens present in liver tumor mass compared to normal liver tissue. The presence of these tumor antigens leads to the production of auto-antibodies, which can be measured for diagnostic purposes. The invention includes a kit that allows for the diagnostic and prognostic measurement of these auto-antibodies in the serum of liver cancer patients. This method is designed to be non-invasive, specific, sensitive, and cost-effective, utilizing a validated set of liver cancer proteins and tumor antigens, including Bmi-1, VCC1, SUMO-4, RhoA, TXN, ET-1, UBE2C, HDGF2, FGF21, LECT2, SOD1, STMN4, Midkine, IL-17A, or IL26.

Career Highlights

Benjamin Chi Yin Wai is currently associated with Dragon Victory Development Ltd. His innovative work has positioned him as a key figure in the advancement of liver cancer diagnostics. His contributions are vital in improving the accuracy and efficiency of cancer detection methods.

Collaborations

He has collaborated with notable colleagues, including Cornelia Wing Yin Man and Norman Fung Man Wai, to further enhance the impact of his inventions in the medical field.

Conclusion

Benjamin Chi Yin Wai's innovative work in the realm of liver cancer diagnosis exemplifies the importance of research and development in medical technology. His contributions are paving the way for more effective and non-invasive diagnostic methods, ultimately benefiting patients worldwide.